Pharmaceuticals
US medical technology company Becton Dickinson to buy C R Bard for $24 bn
24 Apr 2017
The combination of the two companies will create a highly differentiated medical technology company, uniquely positioned to improve both the process of care and the treatment of disease for patients and healthcare providers
Aspen Pharma in midst of cancer drug price-gouging row
17 Apr 2017
Aspen Pharmacare allegedly “plotted to destroy supplies of life-saving cancer medicines” to drive up prices in Europe, after the firm bought the rights to five cancer medicines from GlaxoSmithKline and sought to impose rises of up to 4,000 per cent
